APOE and insomnia measurement: APOE-ε4 homozygotes had a lower prevalence of insomnia (26.7%), compared with heterozygotes (37.7%) and non-carriers (36.6%), although this difference was not statistically significant and could be explained by the homozygous younger mean age.